Jefferies Financial Group’s BioCryst Pharmaceuticals BCRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$1.49M	Buy	+166,577	New	+$1.49M	0.01%	430
2023 Q3	–	Sell	-65,000	Closed	-$458K	–	1153
2023 Q2	$458K	Buy	+65,000	New	+$458K	﹤0.01%	808